Literature DB >> 29688033

Parvalbumin promoter hypermethylation in postmortem brain in schizophrenia.

Helene A Fachim1, Umarat Srisawat1, Caroline F Dalton1, Gavin P Reynolds1.   

Abstract

Deficits of brain parvalbumin (PV) are a consistent finding in schizophrenia and models of psychosis. We investigated whether this is associated with abnormal PV gene (PVALB) methylation in the brain in schizophrenia. Bisulfite pyrosequencing was used to determine cytosine (CpG) methylation in a PVALB promoter sequence. Greater PVALB methylation was found in schizophrenia hippocampus, while no differences were observed in prefrontal cortex. LINE-1 methylation, a measure of global methylation, was also elevated in both regions in schizophrenia, although the PVALB change was independent of this effect. These results provide the first evidence that PVALB promoter methylation is abnormal in schizophrenia and suggest that this epigenetic finding may relate to the reduction of PV expression seen in the disease.

Entities:  

Keywords:  DNA methylation; LINE-1; parvalbumin; postmortem brain; schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 29688033     DOI: 10.2217/epi-2017-0159

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  11 in total

Review 1.  Cytosolic Ca2+ Buffers Are Inherently Ca2+ Signal Modulators.

Authors:  Beat Schwaller
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-01-02       Impact factor: 10.005

Review 2.  Parvalbumin interneuron vulnerability and brain disorders.

Authors:  Jacob B Ruden; Laura L Dugan; Christine Konradi
Journal:  Neuropsychopharmacology       Date:  2020-07-28       Impact factor: 7.853

Review 3.  Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia.

Authors:  Michel Cuenod; Pascal Steullet; Jan-Harry Cabungcal; Daniella Dwir; Ines Khadimallah; Paul Klauser; Philippe Conus; Kim Q Do
Journal:  Mol Psychiatry       Date:  2021-11-10       Impact factor: 13.437

Review 4.  DNA Methylation and Schizophrenia: Current Literature and Future Perspective.

Authors:  Thabo Magwai; Khanyiso Bright Shangase; Fredrick Otieno Oginga; Bonginkosi Chiliza; Thabisile Mpofana; Khethelo Richman Xulu
Journal:  Cells       Date:  2021-10-26       Impact factor: 6.600

Review 5.  The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin.

Authors:  Gavin P Reynolds
Journal:  J Neural Transm (Vienna)       Date:  2021-12-21       Impact factor: 3.850

6.  The Antioxidant N-Acetyl-L-Cysteine Restores the Behavioral Deficits in a Neurodevelopmental Model of Schizophrenia Through a Mechanism That Involves Nitric Oxide.

Authors:  Ana Lopes-Rocha; Thiago Ohno Bezerra; Roberta Zanotto; Inda Lages Nascimento; Angela Rodrigues; Cristiane Salum
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

Review 7.  Can epigenetics shine a light on the biological pathways underlying major mental disorders?

Authors:  Luis Alameda; Giulia Trotta; Harriet Quigley; Victoria Rodriguez; Romayne Gadelrab; Daniella Dwir; Emma Dempster; Chloe C Y Wong; Marta Di Forti
Journal:  Psychol Med       Date:  2022-02-23       Impact factor: 10.592

Review 8.  L1 Retrotransposons: A Potential Endogenous Regulator for Schizophrenia.

Authors:  Muhammad Jahangir; Li Li; Jian-Song Zhou; Bing Lang; Xiao-Ping Wang
Journal:  Front Genet       Date:  2022-06-27       Impact factor: 4.772

9.  Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings.

Authors:  Lukasz Smigielski; Vinita Jagannath; Wulf Rössler; Susanne Walitza; Edna Grünblatt
Journal:  Mol Psychiatry       Date:  2020-01-06       Impact factor: 15.992

10.  Parvalbumin Promoter Methylation Altered in Major Depressive Disorder.

Authors:  Benjamard Thaweethee-Sukjai; Sirijit Suttajit; Samur Thanoi; Caroline F Dalton; Gavin P Reynolds; Sutisa Nudmamud-Thanoi
Journal:  Int J Med Sci       Date:  2019-08-14       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.